ArticleOpen life sciences2026

Taxifolin targets HMGCR, LDLR and APOB to ameliorate hyperlipidemia: insights from systems pharmacology and nanoemulsion-based delivery.

Abdullah R Alanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.